Similar articles

• NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis.

  Schaeffer AJ; National Institute of Diabetes and Digestive and Kidney Diseases of the US National Institutes of Health. Schaeffer AJ, et al. Int J Antimicrob Agents. 2004 Sep;24 Suppl 1:S49-52. doi: 10.1016/j.ijantimicag.2004.02.009. Int J Antimicrob Agents. 2004. PMID: 15364307
• Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community.

  Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, Gao SY, Calhoun EA. Clemens JQ, et al. J Urol. 2005 Dec;174(6):2319-22. doi: 10.1097/01.ju.0000182152.28519.e7. J Urol. 2005. PMID: 16280832
• Prostatitis. A continuing enigma.

  Pfau A. Pfau A. Urol Clin North Am. 1986 Nov;13(4):695-715. Urol Clin North Am. 1986. PMID: 3535211 Review.
• Prostatitis syndromes: an update for urologic practice.

  Nickel CJ. Nickel CJ. Can J Urol. 2000 Oct;7(5):1091-8. Can J Urol. 2000. PMID: 11114871 Review.
• Prostatitis: acute and chronic.

  Ramakrishnan K, Salinas RC. Ramakrishnan K, et al. Prim Care. 2010 Sep;37(3):547-63, viii-ix. doi: 10.1016/j.pop.2010.04.007. Prim Care. 2010. PMID: 20705198 Review.